ACTRN12617001452381
Completed
未知
An Integrative Adapt Therapy (IAT) for Common Mental Health Symptoms and Resilience amongst Chin, Kachin, Rohingya Refugees living in Malaysia
IVERSITY OF NEW SOUTH WALES0 sites331 target enrollmentStarted: October 12, 2017Last updated:
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- IVERSITY OF NEW SOUTH WALES
- Enrollment
- 331
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Inclusion criteria were (a) presence of at least one of the designated common mental disorders (CMDs) that is, current PTSD/CPTSD, MDD, GAD, and PCBD; (b) witnessed or experienced at least one traumatic event related to mass conflict; and (c) endorsed at least one ADAPT\-related stressor on each scale of the relevant measure (see hereunder).
Exclusion Criteria
- •Exclusion criteria were age lower than 18 years, overt evidence of intellectual disability, and the presence of overt cognitive impairment or psychosis (as assessed using the WHO mhGAP protocol.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Integrative Treatment with medications, therapy, diet, and yoga for functional pain disorders: Comparative study by measuring serum inflammatory markersHealth Condition 1: F450- Somatization disorderCTRI/2023/03/050229AIIMS Bhopal
Active, not recruiting
Not Applicable
The effectiveness of the multi-component tailored intervention in treatment of behavioral and psychological symptoms in dementia (BPSD).Behavioral and psychological symptoms in dementia (BPSD)Neurological - DementiasACTRN12610000324011The Central Union for the Welfare of the Aged400
Active, not recruiting
Not Applicable
T CELL DEPLETED HEMATOPOIETIC STEM CELL TRANSPLANT POST REDUCED INTENSITY CONDITIONING AND EARLY USE OF CYCLOPHOPHAMIDE-CLL patients with refractoriness to fludarabine or other chemotherapy due , Follicular lymphoma with either unfavourable cytogenetics such as complex karyotype, del17p, mutations in TP53, minus 1p- Hodgkin's Lymphoma relapsed after autologous transplantation, not elegible for immunotherapy with anti-CD30,-Multiple myeloma relapsing after autologous transplantation, with unfavourable cytogenetics in either partial or complete remissionMedDRA version: 17.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 17.0Level: LLTClassification code 10028567Term: Myeloma, malignantSystem Organ Class: 100000004864MedDRA version: 17.0Level: LLTClassification code 10024341Term: Leukemia lymphoidSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2013-003628-35-ITAzienda Ospedaliero-Universitaria di Parma10
Recruiting
Not Applicable
A blended intervention based on Acceptance and Commitment Therapy (ACT) for Informal Caregivers of People with Dementia- A mixed method approach to evaluate feasibility, acceptability and preliminary effectivenesso specific condition of the informal Caregivers of people with Dementia will be studied.Acceptance and Commitment Therapy for Caregivers of people with DementiaNL-OMON50964niversiteit Maastricht30
Suspended
Not Applicable
Problem adaptation therapy for depression in dementia (PATHFINDER)ISRCTN11185706OCLOR336